Dupilumab Use in Severe Epidermolysis Bullosa Simplex

JAMA Dermatology 2026

View at publisher
Authors: Orsola Crespi, N. Bellon, J. Bonigen, Smail Hadj-Rabia, Fabienne Charbit‐Henrion, Maria Leite-De-Moraes, Christine Bodemer
DOI: 10.1001/jamadermatol.2025.5754
Cited by: 2
References: 6

Abstract

This case report describes treatment with dupilumab in an infant patient with generalized severe epidermolysis bullosa simplex due to a pathogenic variant.

Fields of Study & Subjects

Skin and Cellular Biology Research Autoimmune Bullous Skin Diseases Genetic and rare skin diseases.

Publication details

Journal / source
JAMA Dermatology
Publisher
American Medical Association (AMA)
Volume
162
Issue
4
Pages
423–423
Publication date
25 February 2026
Language
EN